Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or California for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to California only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. California (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Tran (NPI 1205098696)

Key Findings

Field	Value
Entity Type	Individual
Organization	Mark Tran
Address	2121 E Coast Hwy Ste 110
City	Corona Del Mar
State	CA
ZIP	92625
Taxonomy	Dermatology Physician
NPI Enumerated	June 27, 2008

Payer Source	Total Paid
Medicare	$6.5M
Medicaid	$0

This provider is effectively a Medicare-only billing entity: lifetime Medicare revenue is $6.5M while Medicaid revenue is listed as none, so the practice operates as a single-payer (Medicare) commercial footprint in the available data. The absence of any Medicaid billing on file indicates Medicaid is not a material revenue source or payer relationship for this provider.

Revenue is highly concentrated in a small set of diagnostic and procedure codes: the precomputed top 3 Medicare codes account for 57.7% of total Medicare revenue, with Q4234 alone contributing $2.2M (35.5% of Medicare revenue). That concentration signals that a handful of services—particularly the top add-on and pathology codes—drive the majority of collected Medicare dollars.

The code mix points to a pathology- and procedure-driven operation rather than a general outpatient primary-care practice. High-revenue pathology and immunohistochemistry codes such as 88305, 88312, 88341, 88360, and 88344 dominate the list, indicating substantial surgical pathology specimen processing, special stains, and antibody staining work consistent with dermatopathology or biopsy-centric dermatology services.

Several pathology-related codes show extreme deviation from typical national volumes: 88312 (7.2K claims, $758.1K revenue) is labeled an "extreme outlier, far above typical national volume" and ranks #19 of 6966 providers, while 88341, 88360, 88313, and 88344 are also 100th-percentile codes described as extreme outliers or far above typical national volume. These rankings indicate this provider is a major national outlier in laboratory/staining services relative to peers, and the practice likely processes far more pathology workload than typical dermatology clinicians.

Not all high-revenue codes indicate extraordinary market position: Q4234 (3.4K claims, $2.2M revenue) is the single largest revenue contributor but is described as "typical, unremarkable volume for this code" and ranks #2 of 23 providers nationally (95th percentile). This suggests that while Q4234 drives revenue by dollar amount, the underlying utilization pattern for that specific add-on is within expected bounds for the defined peer group, and the provider’s outsized Medicare revenue owes more to volume across multiple pathology codes than to a single anomalous utilization.

Clinical evaluation-and-management (E/M) codes appear modest relative to the pathology mix: 99214 and 99215 are reported at the 91st percentile and labeled typical/unremarkable, together contributing small shares of revenue (e.g., 99214 $57.9K, 99215 $28.2K). This contrast reinforces that direct patient visit revenue is secondary to pathology and procedure-driven revenue streams in this provider’s Medicare profile.

The provider’s national competitive standing is mixed but skewed toward dominance in laboratory services: several procedure codes rank at or near the top nationally (for example, multiple destruction/excision codes are rank #1 for small peer counts and many pathology codes are in the 99–100th percentiles). Collectively this pattern portrays a practice that is a major, even dominant, participant in specific pathology/immunostain services at the national level while being a more typical participant for some procedural add-ons and office visits.

The provider has a long active enrollment history that supports stable operations: NPI was enumerated 2008-06-27 (~18 years ago). That tenure, combined with consistent high-volume pathology coding, suggests an established service model and sustained specialization in biopsy/pathology-related dermatology care over many years.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

52 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
Q4234	Xcellerate, per square centimeter (add-on, list separately in addition to primary procedure)	3,410	$640	$2.2M
88312	The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets…	7,220	$110	$758.1K
88305	The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally…	9,220	$70	$599.4K
88341	The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified…	5,590	$80	$447.5K
88360	The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the…	4,070	$110	$447.5K
88313	The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,…	5,670	$80	$436.3K
88344	The lab analyst applies a single multiplex antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,…	1,720	$160	$271.3K
88342	The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,…	2,460	$90	$228.4K
17286	The provider destroys a malignant lesion on the face, ears, eyelids, nose, lips, or mucous membrane using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. The malignant lesion…	340	$250	$82.1K
17004	The provider destroys 15 or more premalignant lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others.	440	$160	$67.4K

Showing 1–10 of 52

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
Q4234	2	10	1,640	$580	$2.1M
17286	1	10	300	$250	$57.2K
88305	30	1,580	450	$40	$51.3K
17276	1	10	130	$170	$34.7K
17266	1	10	170	$130	$30K
99214	4,529	37,970	120	$90	$23.2K
17284	1	10	140	$160	$23.2K
17274	1	10	100	$120	$19K
15271	47	170	110	$110	$18.6K
11042	175	1,030	100	$80	$18.1K

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Anthony Yniguez	CA	Family Nurse Practitioner	$380.8K	$0
Kaveh Karandish	CA	Internal Medicine Physician	$307.2K	$0
Harish Yalamanchili	CA	Surgery Physician	$276.6K	$0

Mark Tran — Billing Profile & Reimbursement Data

Sign up for Mark Tran — Billing Profile & Reimbursement Data policy alerts

Mark Tran — Billing Profile & Reimbursement Data

Sign up for Mark Tran — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References